Fruquintinib CYP3A Inhibitor and Inducer Study

NCT04557397 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

28

Enrollment

INDUSTRY

Sponsor class

Conditions

Drug Drug Interaction

Interventions

DRUG: Fruquintinib
DRUG: Itraconazole
DRUG: Rifampin

Sponsor

Hutchison Medipharma Limited

Collaborators

[object Object]